Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001700969-26-000002

Options or other derivatives

  • Director acquired 95,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WITTE OWEN N. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-18 Grant or award : show line 1 in the form Restricted Stock Unit +95,400 95,400 D
Loading xslF345X06/wk-form4_1782246596.xml…